4 years ago

Sanome Secures £2 Million Seed Funding to Revolutionize At-Home Diagnostics

  • London-based health startup Sanome has raised £2 million in seed funding to develop its diagnostics innovation engine

  • The platform combines biomarkers to create clinically validated, at-home diagnostic products

  • The funding will be used to expand the team and deliver on key strategic and commercial partnerships.

      • ProblemHealthcare

      "Diagnosing diseases is complex and often requires multiple tests, which can be time-consuming, expensive, and inconvenient for patients."

      Solution

      "Sanome is developing a platform that combines multiple biomarkers and leverages existing digital health technologies to create clinically validated, at-home diagnostic tests that are more efficient, effective, and accessible."

      Covered on